Sandoz
Director, U.S. Policy
Sandoz continues to go through an exciting and transformative period as a global leader and pioneering provider of sustainable biosimilar and generic medicines. As we continue down this new and ambitious path, unique opportunities will present themselves, both professionally and personally. Join us – the future is ours to shape!
Location: Washington, DC office. Our flexible hybrid approach allows US office-based employees to work up to 50% of their monthly workday remotely. This role requires onsite presence; preference will be given to local candidates who do not require relocation.
Major Accountabilities / Key Responsibilities
Lead development and execution of U.S. policy strategies that support access to and reimbursement of generic and biosimilar medicines.
Monitor, analyze, and influence federal policy developments, with a strong focus on CMS reimbursement frameworks.
Represent Sandoz in policy discussions with government agencies, Congressional offices, trade associations, and other external stakeholders.
Collaborate cross‑functionally with Government Affairs, Commercial, Market Access, Legal, and Communications teams to align policy positions and advocacy efforts.
Provide expert policy analysis and synthesize complex regulatory and legislative issues into clear, actionable insights—both in writing and verbally.
Support executive leadership with briefings, policy updates, and strategic recommendations.
Monitor and report regulatory developments relevant to Sandoz’s business and policy objectives.
Qualifications
Bachelor’s degree required; advanced degree in public policy, law, health economics, or related field preferred.
Minimum of 8 years of experience in federal government affairs, public policy, or related roles.
Deep understanding of the pharmaceutical supply chain and its influence on drug pricing and access. Familiarity with CMS, including Medicare Part B and D, is a must.
Strong network of relationships within Capitol Hill and relevant federal agencies.
Exceptional written and verbal communication skills, with the ability to present complex issues succinctly to senior leadership.
Experience working in the U.S. Congress or federal agencies is strongly preferred.
Preferred Qualifications
Familiarity with issues related to generic and biosimilar medicines.
Advanced degree in public policy, law, political science, or a related field.
The pay range for this position at commencement of employment is expected to be between
$176,400 – $327,600
USD/year. Final pay determinations will depend on factors such as geographic location, experience level, knowledge, skills, and abilities. The total compensation package may also include a sign‑on bonus, restricted stock units, and discretionary awards.
Sandoz offers a generous employee benefits package that includes competitive salary, health insurance (medical, prescription drugs, dental and vision), a generous company match for retirement savings accounts, and generous paid time off. The company follows a hybrid work policy that blends in‑person and remote work to provide flexibility.
On September 30, 2021, Sandoz entered into a 5‑year Corporate Integrity Agreement. Certain positions will have responsibilities to support the execution and adherence to CIA obligations, CIA‑related deliverables, and any relevant audit, monitoring or Independent Review Organization (IRO) remediation.
#J-18808-Ljbffr
Location: Washington, DC office. Our flexible hybrid approach allows US office-based employees to work up to 50% of their monthly workday remotely. This role requires onsite presence; preference will be given to local candidates who do not require relocation.
Major Accountabilities / Key Responsibilities
Lead development and execution of U.S. policy strategies that support access to and reimbursement of generic and biosimilar medicines.
Monitor, analyze, and influence federal policy developments, with a strong focus on CMS reimbursement frameworks.
Represent Sandoz in policy discussions with government agencies, Congressional offices, trade associations, and other external stakeholders.
Collaborate cross‑functionally with Government Affairs, Commercial, Market Access, Legal, and Communications teams to align policy positions and advocacy efforts.
Provide expert policy analysis and synthesize complex regulatory and legislative issues into clear, actionable insights—both in writing and verbally.
Support executive leadership with briefings, policy updates, and strategic recommendations.
Monitor and report regulatory developments relevant to Sandoz’s business and policy objectives.
Qualifications
Bachelor’s degree required; advanced degree in public policy, law, health economics, or related field preferred.
Minimum of 8 years of experience in federal government affairs, public policy, or related roles.
Deep understanding of the pharmaceutical supply chain and its influence on drug pricing and access. Familiarity with CMS, including Medicare Part B and D, is a must.
Strong network of relationships within Capitol Hill and relevant federal agencies.
Exceptional written and verbal communication skills, with the ability to present complex issues succinctly to senior leadership.
Experience working in the U.S. Congress or federal agencies is strongly preferred.
Preferred Qualifications
Familiarity with issues related to generic and biosimilar medicines.
Advanced degree in public policy, law, political science, or a related field.
The pay range for this position at commencement of employment is expected to be between
$176,400 – $327,600
USD/year. Final pay determinations will depend on factors such as geographic location, experience level, knowledge, skills, and abilities. The total compensation package may also include a sign‑on bonus, restricted stock units, and discretionary awards.
Sandoz offers a generous employee benefits package that includes competitive salary, health insurance (medical, prescription drugs, dental and vision), a generous company match for retirement savings accounts, and generous paid time off. The company follows a hybrid work policy that blends in‑person and remote work to provide flexibility.
On September 30, 2021, Sandoz entered into a 5‑year Corporate Integrity Agreement. Certain positions will have responsibilities to support the execution and adherence to CIA obligations, CIA‑related deliverables, and any relevant audit, monitoring or Independent Review Organization (IRO) remediation.
#J-18808-Ljbffr